Proposed guidelines for protocol studies. 3. Chronic lymphocytic leukemia. Prepared by a Committee of the Chronic Leukemia--Myeloma Task Force, National Cancer Institute.
D001796:Blood Protein Disorders / Q000276:immunology; D002986:Clinical Trials as Topic; D006801:Humans; D006942:Hypergammaglobulinemia; D007945:Leukemia, Lymphoid / Q000175:diagnosis / Q000188:drug therapy